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Simian immunodeficiency virus strain PBj14, SIVsmmPBj14, is unique among primate lentiviruses in its ability to trigger the
proliferation of resting simian lymphocytes and to cause the rapid death of experimentally inoculated pigtailed macaques.
Severe enteropathy, immune activation, and extensive apoptosis, particularly within gut-associated lymphoid tissue, char-
acterize the acute disease syndrome associated with SIVsmmPBj14 infection. In the present study, we examined whether the
ability of this virus to cause widespread apoptosis might be linked to the up-regulation of Fas ligand (CD95L) expression in
virally infected cells. In vitro studies revealed that expression of the viral Nef protein, in the absence of any other viral gene
product, was sufficient to up-regulate the transcriptional activity of the CD95L promoter and to cause cell surface expression
of Fas ligand. This up-regulation was NFAT dependent (inhibited by cyclosporin A) and did not occur in cells that expressed
a mutated derivative of the viral Nef protein, lacking a previously defined immunoreceptor tyrosine-based activation motif.
These findings were corroborated by analysis of tissue sections from virally infected macaques. Immunohistochemical
staining revealed that Fas ligand expression was efficiently up-regulated in the GALT of animals that had been experimentally
infected with wild-type SIVsmmPBj14 but not in animals that were infected with a nonacutely pathogenic viral mutant lacking
the Nef ITAM. Taken together, these results suggest that the ability of SIVsmmPBj14 to cause acutely lethal disease and to
up-regulate FasL expression may be linked. Additional studies will be required to determine whether the induction of FasL
expression is in itself important for acute disease pathogenesis. © 1998 Academic Press
INTRODUCTION
The acute phase of infection by human immunodefi-
ciency virus-1 (HIV-1) is marked by high levels of virus
replication and widespread viral dissemination in lym-
phoid organs. This initial stage of infection is believed to
strongly influence the progression of subsequent dis-
ease (Lifson et al., 1997; Mellors et al., 1995; Wong et al.,
1996), and it therefore is important to better understand
the viral and host factors that determine the outcome of
primary HIV-1 infection. The analysis of animal models
for HIV/AIDS represents one approach to this problem.
The experimental inoculation of nonhuman primates
with pathogenic strains of simian immunodeficiency vi-
rus (SIV) is a well-defined model for human AIDS and is
characterized by wasting, inversion of the CD4/CD8 ra-
tio, opportunistic infections, and death within 5–18
months postinoculation (Desrosiers, 1990). One strain of
SIV, SIVsmmPBj14, induces an unusually severe acute dis-
ease syndrome in experimentally inoculated pigtailed
macaques (Dewhurst et al., 1990; Fultz et al., 1989). This
syndrome can be characterized as an exaggerated form
of acute HIV-1 infection (Cooper et al., 1985; Cossarizza
et al., 1995; Henrard et al., 1995) and is marked by
enteropathy and by extensive T cell activation, particu-
larly within the gut-associated lymphoid tissues (GALT)
(Fultz and Zack, 1994; Gummuluru et al., 1996;
Schwiebert and Fultz, 1994).
Immune activation has been suggested to be an im-
portant factor in the progression of immunodeficiency
disease (Andrieu et al., 1995), both through its effects on
virus replication (Bukrinsky et al., 1991; Zack et al., 1990)
and through the process of activation-induced T cell
death. Consistent with this, immune activation has been
correlated with apoptosis in SIV-infected macaques
(Gummuluru et al., 1996), and the analysis of molecular
mechanisms regulating programmed cell death has be-
come a central theme in HIV/AIDS research (Ameisen et
al., 1994; Gougeon, 1995; Kaplan and Sieg, 1998).
The CD95 (Fas) receptor/ligand system has been im-
plicated in the process of activation-induced cell death
(AICD) of T cells and may play an important role in the
pathogenesis of AIDS (Nagata and Golstein, 1995). It has
been appreciated for some time that T cell activation
leads to increased levels of Fas ligand (CD95L), and
recent results have shown that Fas ligand expression is
regulated by a number of cellular transcription factors,
including NF-kB, AP-1, Egr-3, and nuclear factor of acti-
vated T cells (NFAT) (Holtz-Heppelmann et al., 1998;
1 To whom reprint requests should be addressed. Fax: (716) 473-2361.
E-mail: stephen_dewhurst@urmc.rochester.edu.
VIROLOGY 252, 354–363 (1998)
ARTICLE NO. VY989477
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
354
Kasibhatla et al., 1998; Latinis et al., 1997; Mittelstadt and
Ashwell, 1998). NFAT binding sites have been identified
in the CD95L promoter and shown to participate in the
upregulation of Fas ligand expression on T-cell activation
(Holtz-Heppelmann et al., 1998; Latinis et al., 1997). Fur-
thermore, specific blockade of NFAT activation using
cyclosporin A prevents up-regulation of Fas ligand after
the exposure of T cells to a variety of stimuli (Holtz-
Heppelmann et al., 1998; Latinis et al., 1997).
Previous studies have shown that among known pri-
mate lentiviruses, SIVsmmPBj14 has the unique ability to
trigger the in vitro proliferation of unstimulated T cells
(Fultz, 1991). This property was found to be dependent on
an immunoreceptor tyrosine-based activation motif
(ITAM) located within SIVsmmPBj14 Nef (Du et al., 1995;
Saucier et al., 1998), and this ITAM was also found to be
necessary for Nef-mediated activation of NFAT in Jurkat
T cells (Luo and Peterlin, 1997). In light of the link be-
tween NFAT activation and Fas ligand expression, we
hypothesized that expression of the SIVsmmPBj14 Nef pro-
tein in T-lymphocytes might be sufficient to trigger the
up-regulation of Fas ligand. To investigate this hypothe-
sis, experiments were conducted to examine whether
expression of the SIVsmmPBj14 Nef in cultured T cells
could elicit (1) an increase in the transcriptional activity
of the CD95L promoter, and (2) up-regulation of cell
surface expression of Fas ligand. In addition, we evalu-
ated Fas ligand expression in intestinal tissue sections
from pigtailed macaques that developed lethal enterop-
athy after infection with SIVsmmPBj14. The results pre-
sented here demonstrate that in the absence of any
other viral gene product, the SIVsmmPBj14 Nef protein was
sufficient to increase transcription from the CD95L pro-
moter, in an NFAT-dependent manner. Cell surface levels
of Fas ligand were also up-regulated by the wild-type Nef
protein, whereas a mutant derivative of SIVsmmPBj14 Nef
lacking the ITAM domain failed to increase CD95L levels.
Finally, immunohistochemical analysis of tissue samples
from the gut of virally infected macaques confirmed that
Fas ligand expression was increased during acute viral
infection in vivo and that this effect was dependent on
the Nef ITAM domain.
RESULTS
Up-regulation of cell surface Fas ligand expression
has been previously shown to occur in response to T cell
activation (Anel et al., 1995). More recently, the activity of
the CD95L promoter element was also found to be reg-
ulated by the transcription factor NFAT (Holtz-Heppel-
mann et al., 1998; Latinis et al., 1997) and to depend on
the activation of the T cell-specific tyrosine kinase,
ZAP-70 (Eischen et al., 1997). Because SIVsmmPBj14 Nef
has been shown to increase the activity of NFAT and to
associate directly with ZAP-70 (Luo and Peterlin, 1997),
we sought to evaluate whether SIVsmmPBj14 Nef could
up-regulate CD95L promoter activity. To test this hypoth-
esis, plasmid expression vectors encoding either the
wild-type SIVsmmPBj14 Nef protein or an ITAM-deleted
version of this protein were constructed (plasmid inserts
were derived from clone PBj6.6 and from its mutated
derivative, clone PBj6.6YERQ, respectively; Novembre et
al., 1993; Saucier et al., 1998). Protein expression from
these plasmids was verified by radioimmunoprecipita-
tion of Nef from transfected COS cells, using a specific
polyclonal antiserum (data not shown).
Jurkat cells then were cotransfected with a reporter
plasmid containing the luciferase gene under the tran-
scriptional control of the CD95L promoter (CD95L-486;
Latinis et al., 1997), together with expression plasmids
encoding either the wild-type or the ITAM-deleted
SIVsmmPBj14 Nef proteins. In control experiments, cells
were transfected with the CD95L reporter plasmid and
then exposed either to medium alone or to the T cell-
activating agent ionomycin. The results of these studies,
which are presented in Fig. 1, show that expression of
wild-type SIVsmmPBj14 Nef, but not of the ITAM-deleted
mutant, was sufficient to cause a substantial (;2-fold)
increase in the transcriptional activity of the CD95L pro-
moter in Jurkat T cells. The extent of promoter activation
was roughly equivalent to that attained using ionomycin
(also ;2-fold) and was consistent with previously re-
ported data (Holtz-Heppelmann et al., 1998). Further-
more, the combination of the wild-type SIVsmmPBj14 Nef
plus ionomycin showed no synergistic effect on FasL
expression compared with the effect of Nef alone (Fig.
1A). This suggested that SIVsmmPBj14 Nef and ionomycin
might act through a common pathway to up-regulate
FasL.
This prediction was experimentally confirmed, by an-
alyzing FasL expression in cells treated with cyclosporin
A. These studies showed that the up-regulation of CD95L
expression by wild-type SIVsmmPBj14 Nef was inhibited on
incubation of the transfected cells in the presence of
cyclosporin A (Fig. 1B). This finding is consistent with the
notion that the viral Nef protein may be acting through
the transcription factor NFAT, as is the case for well-
defined T cell-activating agents such as ionomycin
(Holtz-Heppelmann et al., 1998) and engagement of the T
cell receptor (Latinis et al., 1997).
Because we were able to demonstrate that SIVsmmPBj14
Nef had a positive effect on the transcriptional activity of
the CD95L promoter element, we decided to examine
whether the viral Nef protein could also up-regulate cell
surface expression of the Fas ligand protein. We there-
fore transfected Jurkat T cells with Nef expression plas-
mids (wild type or ITAM deleted), together with a vector
encoding the murine Thy-1.2 antigen. Flow cytometric
analysis of Thy-1.2 expression was then used to identify
successfully transfected cells, and Fas ligand levels
were evaluated in this subpopulation of cells. These
experiments revealed that SIVsmmPBj14 Nef caused an
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up-regulation of cell surface Fas ligand expression (Fig.
2A), whereas the ITAM-deleted Nef mutant did not (Fig.
2B).
Having demonstrated that expression of SIVsmmPBj14
Nef was sufficient to trigger an increase in Fas ligand
expression in cultured human T cells, we wanted to
examine whether this antigen was also up-regulated in
macaques that had been infected with either wild-type or
ITAM-deleted molecular clones of SIVsmmPBj14. For these
experiments, we availed ourselves of cryopreserved tis-
sue samples from pigtailed macaques that were killed
after acute infection with the PBj6.6 molecular clone of
SIVsmmPBj14 or after infection with the molecular clone
PBj6.6 Y-R, which is isogenic to PBj6.6, with the excep-
tion of a single point mutation within the Nef ITAM (Sauc-
ier et al., 1998). In addition, specimens from SIV-seroneg-
ative pigtailed macaques were examined (Gummuluru et
al., 1996).
Intestinal tissue specimens, corresponding to gut-as-
sociated lymphoid tissue, were subjected to immunohis-
tochemical staining for Fas ligand using a specific mono-
clonal antibody (Nok1; Pharmingen). Representative re-
sults are shown in Fig. 3. It can be readily appreciated
that the number of cells that exhibit dark cytoplasmic
staining (indicative of Fas ligand expression) is markedly
higher in Fig. 3A (intestinal tissue from a macaque in-
fected with PBj6.6) than in the remainder of the figure
(respectively, tissue from a macaque infected with PBj6.6
Y-R or from an SIV-seronegative animal). Thus at a qual-
itative level, it was apparent that there was an increase
in the expression of Fas ligand in GALT from macaques
that had died as a result of acute infection with wild-type
SIVsmmPBj14 compared with animals infected with the
ITAM-deleted mutant or SIV-negative macaques. To con-
firm this interpretation, multiple tissue sections were
subjected to immunohistochemical staining for Fas li-
gand. Intestinal tissues from macaques that were killed
at 6 days after infection with the PBj6.6 molecular clone
(Gummuluru et al., 1996) were analyzed, as well as tis-
sues from macaques that were killed at 6 or 10 days
after infection with the PBj6.6 Y-R clone (Saucier et al.,
1998) and specimens from SIV-seronegative animals
(Gummuluru et al., 1996). In each case, tissues from two
animals were examined; this sample size was dictated
by the limited availability of tissues, notably, only two
macaques were killed at acute time points after infection
with the PBj6.6 Y-R clone (Saucier et al., 1998).
Quantitative analysis of immunohistochemical staining
from these specimens is presented in Fig. 4, which
shows that Fas ligand expression was increased by
;2-fold in the GALT of macaques that were infected with
wild-type SIVsmmPBj14 (clone PBj6.6) compared with ma-
caques that were infected with the ITAM-deleted virus
mutant (clone PBj6.6 Y-R) or uninfected macaques (no
SIV). This difference was statistically significant (P ,
0.00001). It also is apparent that there was a modest
up-regulation of FasL expression in GALT from animals
infected with clone PBj6.6 Y-R compared with SIV-nega-
tive controls (P , 0.05).
In light of the increase in both FasL expression (Figs.
3 and 4) and apoptosis (Gummuluru et al., 1996) in
intestinal tissues from SIVsmmPBj14-infected macaques,
FIG. 1. SIVsmmPBj14 Nef up-regulates the transcriptional activity of the
CD95L promoter. Jurkat T cells were transfected with a plasmid con-
taining the luciferase gene, under the transcriptional control of the
CD95L promoter (CD95L; see Materials and Methods), in the presence
or absence of constructs expressing the SIVsmmPBj14 Nef protein. Two
Nef expression vectors were used in these studies: (1) a vector encod-
ing wild-type SIVsmmPBj14 Nef (1 Nef) and (2) a vector encoding an
ITAM-deleted mutant of SIVsmmPBj14 Nef (1 Nef-M). (A) Jurkat cells were
transfected with the reporter plasmid alone (CD95L) or with the reporter
plasmid plus a Nef expression plasmid (as indicated) and then ex-
posed to ionomycin (1 iono) or to culture medium alone. Dark bars
represent cells that were not exposed to ionomycin, and the shaded
bars denote ionomycin-treated cells. The data shown represent nor-
malized mean levels of luciferase activity (see Materials and Methods),
calculated from a single experiment in which each condition was
performed four times; the bars represent the S.E.M. This experiment
was repeated on three occasions, with similar results. (B) Aliquots of
Jurkat cells were transfected with the reporter plasmid alone (CD95L)
and then exposed to ionomycin (1 iono), or cells were transfected with
reporter plasmid plus Nef expression plasmids (as indicated). The
transfected Jurkat cells were exposed to these treatments in the pres-
ence and absence of cyclosporin A (CsA). Dark bars represent cells
that were not incubated in the presence of CsA, and open (unshaded)
bars represent CsA-treated cells. The data shown represent normal-
ized mean levels of luciferase activity (see Materials and Methods),
calculated from a single experiment in which each condition was
performed six times; the bars represent the S.E.M. This experiment was
repeated on four occasions, with similar results.
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we performed dual labeling experiments so as to colo-
calize apoptotic cells and FasL-positive cells within the
same tissue section. The results, shown in Fig. 5, re-
vealed that most of the apoptotic (TUNEL-positive) cells
within GALT were also positive for Fas ligand. However,
occasional cells were found to be TUNEL positive but
Fas ligand negative. These cells were often located in
close proximity to Fas ligand-expressing cells (e.g., the
cell denoted by the arrow in Fig. 5).
DISCUSSION
Studies in rhesus macaques infected with nef-deleted
strains of SIV have demonstrated that this gene is nec-
essary for high levels of viral replication and for the
consistent induction of immunodeficiency disease in ma-
ture animals (Kestler et al., 1991; Novembre et al., 1996).
Evidence for the involvement of nef in HIV-1 pathogene-
sis is less direct but includes the fact that nef-deleted
strains of HIV-1 exhibit attenuated pathogenicity in
SCID-hu mice (Aldrovandi and Zack, 1996), as well as the
observation that some HIV-1-positive individuals with
nonprogressive disease harbor nef-deleted viral strains
(Deacon et al., 1995; Kirchhoff et al., 1995). These find-
ings have heightened interest in the biochemical and
biological properties of Nef, which include the ability to
down-regulate CD4 expression, to perturb T cell signal-
ing, to associate with cellular kinases, and to enhance
the infectivity of viral particles (Cullen, 1994; Mangasar-
ian and Trono, 1997).
The nef allele from SIVsmmPBj14 is unique in that it
contains an immunoreceptor tyrosine-based activation
motif (ITAM; [YxxL] xxxxxxx [YxxL]) close to its N-terminus
(Du et al., 1995). When inserted into certain other strains
of SIV, this element is sufficient to confer an acutely
pathogenic and lymphoproliferation-inducing phenotype
on the resulting recombinant virus (Du et al., 1996, 1995;
Sasseville et al., 1996). Furthermore, the elimination of
the Nef ITAM from an acutely lethal molecular clone of
SIVsmmPBj14 resulted in the attenuation of viral pathoge-
nicity and the loss of the ability to induce lymphoprolif-
eration (Saucier et al., 1998). These data provide com-
peling evidence for the role of the SIVsmmPBj14 Nef ITAM
in the induction of acute disease and T cell activation.
The discovery that SIVsmmPBj14 Nef associates directly
with the T cell-specific tyrosine kinase ZAP-70 and the
observation that intracellular expression of SIVsmmPBj14
Nef leads to the activation of the transcription factor
NFAT (Luo and Peterlin, 1997) provoked us to consider
whether this virally encoded protein might influence the
expression of ZAP-70-dependent and NFAT-regulated
genes, such as Fas ligand (Eischen et al., 1997; Holtz-
Heppelmann et al., 1998; Latinis et al., 1997). We con-
FIG. 2. Effect of SIVsmmPBj14 Nef on cell surface expression of Fas ligand in Jurkat cells. Jurkat T cells were transfected with expression plasmids
encoding wild-type (A) or ITAM-deleted (B) SIVsmmPBj14 Nef, together with a plasmid encoding the murine Thy-1.2 antigen (see Materials and Methods).
Thy-1.2 positive (i.e., successfully transfected) cells were identified using FITC fluorescence. The level of Fas ligand expression was then determined
within this FITC-positive subpopulation, using the Cy5 fluorochrome. This experiment was repeated four times with similar results. Data from one
representative experiment are presented; the gray histogram represents cells incubated with the secondary, Cy5-conjugated, antibody alone, and the
black histogram represents cells that were stained with a monoclonal antibody directed against Fas ligand and then reacted with the secondary
antibody. Note the increase in Fas ligand expression within the wild-type Nef transfectants (A) compared with cells transfected with the ITAM-deleted
Nef mutant (B).
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ducted our initial studies using SIVsmmPBj14 Nef expres-
sion vectors, which were introduced into Jurkat T cells
via transient transfection. This approach permitted us to
examine the effects of Nef on FasL expression in the
absence of other viral gene products such as gp120 and
Tat, which have (at least in the case of HIV-1) been
reported to up-regulate Fas ligand expression (Westen-
dorp et al., 1995).
Our experiments revealed that SIVsmmPBj14 Nef up-
regulated the transcription of the CD95L promoter and
elicited an increase in cell surface expression of Fas
ligand (Figs. 1 and 2). As expected, the effects of the viral
Nef protein were dependent on activation of NFAT (i.e.,
they were inhibited by cyclosporin A; Fig. 1B). In addition,
we were able to show that the effects of Nef on FasL
expression were dependent on the presence of an intact
ITAM because an ITAM-deleted Nef mutant was incapa-
ble of up-regulating Fas ligand expression (Figs. 1 and 2).
Analysis of tissue specimens from the GALT of pig-
tailed macaques that were killed within 6–10 days of
infection with SIVsmmPBj14 confirmed our in vitro findings
and demonstrated that a wild-type viral molecular clone
triggered a ;2-fold up-regulation of FasL expression
(Figs. 3 and 4). A significant level of FasL expression was
also detected in tissues from control (SIV negative) pig-
tailed macaques, presumably reflecting the generalized
state of immune activation that exists within intestinal
lymphoid tissue and the fact that FasL expression can be
detected in a proportion of T cells within normal gut
tissue (De Maria et al., 1996). In addition, a slight in-
crease in FasL expression was detected in tissues from
animals infected with the ITAM-deleted of SIVsmmPBj14
(Fig. 4). This finding may be analogous to the FasL-
inducing effect of more prototypical (ITAM-negative) SIV
strains, such as SIVmac32H (Xu et al., 1997), and could
reflect the fact that the ITAM-negative Nef had a modest
additive effect on the transcriptional activity of the CD95L
promoter in ionomycin-treated Jurkat cells (Fig. 1A).
Acute SIVsmmPBj14 infection has previously been
shown to be associated with increased levels of apopto-
sis and immune activation within GALT (Gummuluru et
al., 1996). When the spatial localization of apoptotic cells
and Fas ligand-positive cells within a single tissue spec-
imen was examined directly, we observed that the ma-
jority of the apoptotic cells were positive for Fas ligand
(Fig. 5). However, some apoptotic cells were found to be
negative for Fas ligand; these cells were often located in
close proximity to Fas ligand positive cells (Fig. 5, arrow).
Additional immunohistochemical studies, using an
anti-CD3 monoclonal antibody (SP34, Pharmingen) in
combination with the TUNEL reagent (see Materials and
Methods), confirmed that the apoptotic cells detected
within these SIV-infected tissue specimens were pre-
dominantly CD31 T lymphocytes (data not shown). Thus
the FasL-negative, TUNEL-positive cells that were de-
tected in the immediate vicinity of Fas ligand-positive
cells could represent “bystander” T-lymphocytes that had
undergone Fas ligand-mediated cell killing. Neverthe-
less, the data in Fig. 5 show that contact between FasL-
expressing T cells and TUNEL-positive, FasL-negative
“targets” is relatively uncommon. Rather, it would appear
that the up-regulation of FasL expression may induce
apoptosis via an autocrine mechanism, as has been
described after T cell receptor-mediated activation of
cultured T lymphocytes (Brunner et al., 1995; Dhein et al.,
1995; Lenardo et al., 1995; Su et al., 1998).
The presence of an intact Nef ITAM is a requirement
not only for the efficient up-regulation of Fas ligand (Figs.
3 and 4) but also for the immune-activating and apopto-
sis-inducing effects of SIVsmmPBj14 (Saucier et al., 1998).
In light of the severe enteropathy that occurs during
acute viral infection, it is interesting to consider the fact
that FasL expression by intestinal intraepithelial lympho-
cytes has been shown to lead to apoptosis of intestinal
epithelial cells (Lin et al., 1998; Strater et al., 1997). FasL
expression may also contribute to the profound depletion
of intestinal CD41 T cells that occurs during the acute
phase of SIV infection (Smit-McBride et al., 1998; Veazey
et al., 1998) because T cells from GALT are known to be
hypersensitive to Fas/FasL-mediated apoptosis (De
Maria et al., 1996). Additional studies will be required to
examine whether viral induction of FasL expression
within GALT may contribute directly to the pathogenesis
of acute SIVsmmPBj14 infection in pigtailed macaques.
In a broader sense, the relationship between apopto-
sis and infection by primate lentiviruses remains a con-
FIG. 4. Quantitative analysis of Fas ligand expression in simian
tissues. The mean number of FasL-positive cells per high-power mi-
croscope field is shown for GALT sections collected from pigtailed
macaques that were killed within 6–10 days of infection with wild-type
SIVsmmPBj14 (PBj6.6) or with an ITAM-negative viral mutant (PBj6.6 Y-R).
In addition, tissues from SIV-seronegative pigtailed macaques were
also analyzed (no SIV). In all cases, a total of eight microscope fields,
for each of two animals (per condition), were examined. Data represent
the mean number of positive cells per high-power field; bars represent
the S.E.M. values.
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troversial and intensively studied topic (Kaplan and Sieg,
1998). Both HIV-1 and SIV have been shown to up-
regulate the expression of FasL in cultured cells (Badley
et al., 1996; Dockrell et al., 1998; Mitra et al., 1996; Xu et
al., 1997). Furthermore, increased levels of FasL have
been detected in tissue macrophages from HIV-1-in-
fected persons (Dockrell et al., 1998), as well as on
T-lymphocytes isolated directly from the blood of individ-
uals with chronic HIV-1 infection (Mitra et al., 1996;
Sloand et al., 1997) or macaques with chronic SIV infec-
tion (Xu et al., 1997). Our findings differ from these pre-
vious reports in at least two respects. First, we focused
exclusively on events that occur during the very early
stages of a severe immunodeficiency virus infection.
Second, we have shown that the unique nef allele from
SIVsmmPBj14 is both necessary and sufficient for the in-
duction of Fas ligand expression. In contrast, Xu et al.
(1997) showed that Nef was necessary for up-regulation
of FasL by SIVmac32H but could not demonstrate that Nef
alone was sufficient to mediate this effect.
In summary, this study provides strong evidence that
the unique nef allele from SIVsmmPBj14 is both necessary
and sufficient to trigger the up-regulation of FasL expres-
sion in T cells and that this property depends on the
presence of a previously defined ITAM motif within Nef.
This finding may have important implications for the
immunopathogenesis of acute SIVsmmPBj14 infection.
MATERIALS AND METHODS
Plasmid constructs
For the present study, the following oligonucleotide
primers were used to PCR amplify and clone SIVsmmPBj14
nef sequences: (1) NefA, 59-agcggatccAGTATGGGTG-
GCGTTACCTCCA; and (2) NefC, 59-agcgaattcgcggccgc-
TTAACCCATTTGCTGTCCACCAGTCATGCTAGCCATGCT-
TGTTTTCTTCTTGTCAGCCAT. Primer NefA includes the
authentic nef start codon (shown in boldface lettering),
together with a BamHI site for cloning (GGATCC),
whereas primer NefC includes an EcoRI site for cloning
(GAATTC), as well as a stop codon (shown in boldface
lettering) and a T7 epitope tag (MASMTGGQQMG) fused
to the C-terminus of the nef open reading frame (the final
nef codon, immediately preceding the T7 tag, is under-
lined). Viral nef alleles were PCR amplified using Pfu
DNA polymerase, cloned upstream of a cytomegalovirus
promoter–enhancer in plasmid pCA14 (Microbix Biosys-
tems, Toronto, Canada) (Bett et al., 1994) and then se-
quenced to verify the authenticity of the resulting nef
sequences.
The nef alleles were subcloned from (1) the acutely
lethal wild-type PBj6.6 molecular clone (wild-type Nef)
and (2) an otherwise isogenic molecular clone of
SIVsmmPBj14 bearing two point mutations within the Nef
ITAM domain (mutant Nef). This ITAM-deleted molecular
clone (designated PBj6.6YERQ) contains mutations that
result in the substitution of wild-type SIVsmmPBj14 se-
quences (YE) for the corresponding residues from a
nonacutely lethal strain of SIV, SIVmac239 (RQ), at Nef
amino acid residues 17 and 18. The resulting virus fails to
induce lymphoproliferation in vitro and does not cause
acutely lethal disease in vivo (Saucier et al., 1998).
Cell lines and transfections
The human T cell line Jurkat was maintained in RPMI
1640 medium (Life Technologies Inc., Bethesda, MD)
supplemented with 10% fetal calf serum (Sigma Chemi-
cal, St. Louis, MO), 0.2 mM glutamate, 50 U/ml penicillin,
and 50 mg/ml streptomycin (Life Technologies). Jurkat
cells (2 3 106 per condition) were transfected with plas-
mid DNAs using SuperFect transfection reagent (Qiagen,
Santa Clarita, CA), using conditions recommended by the
manufacturer; 3 mg of Nef-expressing plasmid was used
per transfection, together with 5 mg of a CMV-bgal re-
porter (internal control) and 10 mg of the CD95L486
reporter plasmid (this construct contains a luciferase
reporter gene, under the transcriptional control of the
CD95L promoter, and was generously provided by Dr.
Gary Koretzky; Latinis et al., 1997). After transfection,
cells were washed in 13 PBS, resuspended in RPMI
1640 medium supplemented with fetal calf serum, and
plated onto 60-mm dishes. Ionomycin (1 mg/ml; Sigma)
and/or cyclosporin A (10 mg/ml; Sigma) was added as
appropriate.
Luciferase assays
Jurkat cells were harvested 48 h after transfection with
plasmid DNAs and resuspended in 13 Reporter Lysis
Buffer (Promega Corp., Madison, WI) for 15 min. Lucif-
erase activity was then determined by using a Lumi-
Count luminometer (Packard Instrument Company, Meri-
den, CT). Each experimental condition was assayed in
replicates of six, and transfection efficiencies were nor-
malized by measuring expression of the internal control
plasmid, using the b-galactosidase Enzyme Assay Sys-
tem (Promega).
Flow cytometry
For analysis of cell surface CD95L expression, Jurkat
cells (2 3 106) were transfected with plasmid constructs
encoding SIVsmmPBj14 Nef, together with a vector encod-
ing the murine Thy-1.2 antigen (gift of Dr. Vicente
Planelles). Forty-eight hours later, CD95L and Thy-1.2
expression were analyzed as follows. First, cells were
incubated with the anti-human CD95L monoclonal anti-
body Nok-1 (1:100; Pharmingen, San Diego, CA), followed
by a secondary, Cy5-conjugated, goat anti-mouse IgG1
antibody (Caltag Laboratories, Burlingame, CA). Second,
Thy-1.2 expression was detected using a monoclonal
antibody, 53-2.1, directly conjugated to FITC (1:100;
Pharmingen). Cells treated with secondary antibody
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alone were used as negative controls. Flow analysis was
performed using a Coulter Epics Elite ESP (Coulter Corp.,
Hialeah, FL).
Tissues and immunohistochemistry
Tissue specimens were obtained at necropsy from
SIV-seronegative pigtailed macaques and from pigtailed
macaques infected with molecular clones of SIVsmmPBj14
containing wild-type (clone PBj6.6) or mutant (clone
PBj6.6YERQ) nef sequences. Tissues were frozen imme-
diately at 280°C and then sectioned to 5-mm thickness
onto Vectabond (Vector Labs., Burlingame, CA)-coated
slides. FasL-expressing cells were detected using Nok-1
antibody, and visualization of positively stained cells was
achieved via the avidin–biotin complex (ABC) method
(Vector Labs.) using a peroxidase–avidin conjugate with
diaminobenzidine (DAB) as the chromagen (this results
in a dark-brown or black cytoplasmic stain in antigen-
positive cells); counterstaining was performed with he-
motoxylin, as described previously (Dollard et al., 1995).
Digitized images of immunohistochemically stained sec-
tions in eight 403 microscopic fields (per section) were
then analyzed for numbers of antigen-positive cells
using a densitometer (Imaging Research Inc., Ontario,
Canada), as previously described (Gelbard et al., 1995;
Gummuluru et al., 1996). Data were expressed as the
mean number of positive cells per high-power microscopic
field 6 S.E.M. Tests of statistical significance between
sample groups were determined by paired t tests.
Colocalization experiments, which involved the simul-
taneous detection of apoptotic cells and FasL-positive
cells within the same tissue section, were performed
using the TUNEL method (to identify apoptotic nuclei)
with DAB as the chromagen, together with the Nok-1
antibody (to identify FasL-positive cells) with New Fuch-
sin as the chromagen. TUNEL-positive cells therefore
contained darkly stained nuclei (black), whereas FasL-
positive cells were identified by a red cytoplasmic stain.
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